Drug Delivery across Blood Brain Barrier Market size is estimated to reach $ 4,627.3 million by 2026, growing at a CAGR of 5% over 2021-2026. The blood brain barrier helps to protect the brain from harmful chemicals and maintains a constant environment. The blood brain barrier is a kind of protecting structure that provides control on passage that moving from blood to the tissues of the central nervous system. Liposomes are an important tool to transfer drugs across the blood brain carrier owing to their flexible properties. The blood brain barrier are formed by the brain microvascular endothelial cells, a central element of the microvasculature that guard the brain against toxins. Growing incidence of neurological disorders and rising technological advancements is the major factor driving the growth of this market. Furthermore, rising prevalence of dementia and development in magnetic resonance imaging helps to detect blood brain barrier that can predict stroke patient’s is set to further enhance the overall market demand for Drug Delivery across Blood Brain Barrier Market for the period 2021-2026.
Drug Delivery Across Blood Brain Barrier Market Segment Analysis – By Technology
The global Drug Delivery across Blood Brain Barrier Market based on Technology can be further segmented into Trojan Horse Approach, Bispecific Antibody RMT Approach, Increasing Permeability, Passive Diffusion, Others. The Increasing Permeability of blood brain barrier segment is the major segment generating revenue in 2020. This is owing to rising number of research activities for the treatment of various neurological and CNS (Central Nervous System) Disorders. The Trojan Horse Approach segment is estimated to register the fastest CAGR of 3.8% for the period 2021-2026. This is owing to increasing demand of biologics for treating brain disorders. Biologics are also considered as a new therapy for treating most CNS (Central Nervous System) disorders.
Drug Delivery Across Blood Brain Barrier Market Segment Analysis – By Application
The global Drug Delivery across Blood Brain Barrier Market based on Application can be further segmented into Alzheimer’s Disease, Epilepsy, Parkinson’s Disease, Multiple Sclerosis, Hunter’s Syndrome, Brain Cancer, Others. The Parkinson’s Disease segment registers for the highest market share in 2020. According to National institute on Aging, in 2020 about 5-10% of people have parkinson’s at the age of 50 and are mostly occur in men. The Epilepsy segment is estimated to register the fastest CAGR of 1.2% over 2021-2026. According to World Health Organization in 2019, about 50 million people are affected by epilepsy which increases the growth of this segment.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=19550
Report Price: $ 4500 (Single User License)
Drug Delivery Across Blood Brain Barrier Market Segment Analysis – By Geography
North America dominated the Drug Delivery across Blood Brain Barrier Market with major share of 45% in 2020. This is owing to increasing adoption of advanced technology for treating severe life-threatening disorders, rising prevalence of Hunter’s and Azheimer’s syndrome. According to National Institute of Health, about 5.5 million Americans are suffering from Alzheimer’s in 2020 which are contributing to the rise in market growth.
However, Asia-Pacific is estimated to outpace all the regions by clocking the highest CAGR of 20% during the forecast period 2021-2026 owing to the increasing geriatric population and improving innovative technologies.
Drug Delivery across Blood Brain Barrier Market Drivers
Growing Incidence of Neurological Disorders
The increasing prevalence of neurological diseases such as meningitis, multiple sclerosis, Parkinson’s disease, and encephalitis, growing geriatric population increases the growth of the Drug Delivery across Blood Brain Barrier Market. Moreover, rising demand for treatment and rise in the innovations helps safe and reliable transmission of medication. Thus, increasing the growth of the Drug Delivery across Blood Brain Barrier Market over 2021-2026.
Rising Technological Advancement
Growing technological advancement and rising healthcare sector is increasing the growth of the Drug Delivery across Blood Brain Barrier Market. Moreover, increasing use of nanotechnology in treating various medical conditions and rising development in magnetic resonance imaging increases the growth of Drug Delivery across Blood Brain Barrier Market over 2021-2026.
Covid-19 Impact:
COVID-19 is adversely impact the growth of Drug Delivery across Blood Brain Barrier Market. Moreover, recent clinical studies believed that people suffering from Central Nervous System complications are more susceptible to COVID-19 infection owing to low immunity that positively affected the growth of Drug Delivery across Blood Brain Barrier Market.
Drug Delivery across Blood Brain Barrier Market Challenges
Leakage in Blood Brain Barrier
The factors that is set to impede the growth of the Drug Delivery across Blood Brain Barrier Market are the rising risk in leakage of blood brain barrier that can enter harmful substances. Moreover, it takes out all the nutrients is set to create hurdles for the Drug Delivery across Blood Brain Barrier Market.
Drug Delivery across Blood Brain Barrier Industry Outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Drug Delivery across Blood Brain Barrier Market. Key companies of this market include Ossianix, Inc., Amneal Pharmaceuticals Inc., Insightec, Angiochem Inc., Armagen Technologies, Inc., BrainsGate, BiOasis Technologies, Inc., CarThera, F. Hoffman La-Roche, and Iproteos S.L.
Acquisitions/Product Launches
In November 2019, SK Biopharmaceuticals launches an anti-epileptic drug XCOPRI which also receives FDA approval.
Key Takeaways
Geographically, in 2020 North America dominated the Drug Delivery across Blood Brain Barrier Market owing to increasing adoption of advanced technology for treating severe life-threatening disorders, rising prevalence of hunter’s and alzheimer’s syndrome.
Growing incidence of neurological disorders and rising technological advancements are likely to aid in the market growth of the Drug Delivery across Blood Brain Barrier.
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Drug Delivery across Blood Brain Barrier Market report.
Leakage in blood brain barrier is set to create hurdles for the Drug Delivery across Blood Brain Barrier Market.
Related Reports :
A. Nanotechnology Drug Delivery Market
https://www.industryarc.com/Report/16071/nanotechnology-drug-delivery-market.html
B. Drug Delivery Market
https://www.industryarc.com/Report/10599/drug-delivery-market-analysis.html
For more Lifesciences and Healthcare Market reports, Please Click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
Media Contact
Company Name: IndustryARC
Contact Person: Mr. Venkat Reddy
Email: Send Email
Phone: 1-614-588-8538 (Ext: 101)
Address:Madhapur
City: Hyderabad
Country: India
Website: http://industryarc.com/